跳至主要内容
临床试验/IRCT201307141030N15
IRCT201307141030N15已完成2 期

Efficacy of calcitriol in prevention of high dose chemotherapy induced mucositis in patients with Fanconi anemia undergoing Hematopoietic Stem Cell Transplantation

Hematology Oncology and SCT Research Center0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
1 year 至 15 years(—)
性别
All

入选标准

  • Inclusion criteria:
  • 1- Patients with Fanconi anemia
  • 2- Age limit 1-15 years
  • 3- Patient’s Parents or guardians’ informed consent
  • Exclusion criteria:
  • 1- 25-OH vitamin D >100 ng/ml
  • 2- Ca>10 mg/dl
  • 3- P>4.6 mg/dl
  • 4- give vitamin D supplementation within past three months

排除标准

  • 未提供

研究者

发起方
Hematology Oncology and SCT Research Center

相似试验

已完成
2 期
calcirtiol effect in contrast induced nephropathyeffect of calcitriol in preventing contrast induced nephropathy in patients with renal function undergoing coronary angiography or intervention..
IRCT20160412027346N7Shahid Beheshti University of Medical Sciences236
已完成
2 期
The dose of preoperative calcitriol to prevent postoperative hypocalcemia after parathyroidectomy in end stage kidney disease : a randomized controlled clinical trialEnd stage kidney disease with renal hyperparathyroidism undergoing parathyroidectomyParathyroidectomy, hemodialysis, hypocalcemia
TCTR20240315002Phramongkutklao hospital and college of medicine, bangkok28
已完成
2 期
Evaluation of the effect of calcitriol supplementation on diabetes control and its complications in hyperlipidemic patients with type 2 diabetes mellitus, Shiraz, 2009
IRCT138806282480N1Shiraz university of medical sciences70
招募中
3 期
Calcitriol supplementation in Nonalcoholic Fatty Liver Diseaseon-Alcoholic Fatty Liver disease (NAFLD).Fatty (change of) liver, not elsewhere classified
IRCT2017053034222N1Ahvaz Jundishapur University of Medical Sciences160
已完成
2 期
Effects of calcitriol on the complications of hematopoietic stem cell transplantatioHodgkin lymphomaCondition 1: Hodgkin lymphoma. Condition 2: Non-Hodgkin lymphoma. Condition 3: Multiple myeloma.Follicular lymphoma, Non-follicular lymphoma, Mature T/NK-cell lymphomas, Other and unspecified types of non-Hodgkin lymphomaMultiple myeloma and malignant plasma cell neoplasmsC82, C83,
IRCT2016052727435N2Research Center of the Hematology and Oncology and Stem Cell Transplantation, Shariati Hospital80